Baird Financial Group, Inc. Horizon Therapeutics Public LTD CO Transaction History

Baird Financial Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $935,064 - $1.09 Million	-9,447 Reduced 51.79%	8,793 $1.02 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $1.25 Million - $1.46 Million	12,976 Added 246.5%	18,240 $1.88 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $564,932 - $597,464	5,264 New	5,264 $574,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $166,358 - $211,384	-1,925 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$98.56 - $119.91 $189,728 - $230,826	1,925 New	1,925 $207,000
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $243,010 - $291,818	-2,644 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$86.24 - $95.92 $228,018 - $253,612	2,644 New	2,644 $248,000
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $487,680 - $705,781	-8,830 Closed	0 $0
Q2 2020 Oct 22, 2020	SELL	$30.2 - $56.98 $1,993 - $3,760	-66 Reduced 0.74%	8,830 $491,000
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $268,659 - $506,894	8,896 New	8,896 $475,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.